PTCT - CIK 0001070081
The table below shows PTC THERAPEUTICS, INC.'s balance sheet by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q1 2026 | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $833.99M | $672.62M | $1.02B | $1.48B | $526.00M | $654.78M |
| Short-term investments | $1.06B | $1.02B | $971.76M | $546.95M | $487.36M | $438.51M |
| Receivables | - | - | - | - | - | - |
| Inventory | $75.57M | $52.69M | $34.06M | $21.68M | $35.67M | $31.83M |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Total current assets |
| $2.25B |
| $2.01B |
| $2.27B |
| $2.32B |
| $1.28B |
| $1.36B |
| Property, plant & equipment | $52.74M | $56.97M | $57.19M | $59.46M | $63.17M | $65.99M |
| Goodwill | $82.34M | $82.34M | $82.34M | $82.34M | $82.34M | $82.34M |
| Total assets | $2.87B | $2.64B | $2.63B | $2.66B | $1.84B | $1.92B |
| Accounts payable | $25.48M | $36.62M | $26.50M | $15.15M | $13.29M | $24.28M |
| Total current liabilities | $923.60M | $866.25M | $627.81M | $595.39M | $610.71M | $609.80M |
| Long-term debt | - | $285.41M | $286.01M | $285.71M | $285.11M | $284.81M |
| Total liabilities | $3.05B | $2.80B | $2.84B | $2.84B | $2.90B | $2.90B |
| Retained earnings | -$2.97B | -$2.83B | -$2.85B | -$2.78B | -$3.58B | -$3.47B |
| Total equity | -$180.47M | -$155.76M | -$206.55M | -$185.76M | -$1.05B | -$980.18M |